BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou F, Sun X. Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:762828. [PMID: 34869352 DOI: 10.3389/fcell.2021.762828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zunica ERM, Heintz EC, Axelrod CL, Kirwan JP. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4051. [PMID: 36011044 DOI: 10.3390/cancers14164051] [Reference Citation Analysis]
2 Wei RL, Fan GH, Zhang CZ, Chen KC, Zhang WH, Li CB, Dong SY, Chen JL, Ling SB, Zheng SS, Xu X. Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00123-0. [PMID: 35613994 DOI: 10.1016/j.hbpd.2022.05.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Coleman PS, Parlo RA. Cancer’s Camouflage — Microvesicle Shedding from Cholesterol-Rich Tumor Plasma Membranes Might Blindfold First-Responder Immunosurveillance Strategies. European Journal of Cell Biology 2022. [DOI: 10.1016/j.ejcb.2022.151219] [Reference Citation Analysis]